Sight Sciences
Develops interventional devices for glaucoma surgery and dry eye treatment.
$8.55
After-hours close+0.02 (+0.23%)
At close$8.53(+1.43%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.13 | — | — |
| Aug 2026 | −$0.18 | −$0.08 | +56.4% |
| May 2026 | −$0.19 | −$0.16 | +15.8% |
| Mar 2026 | −$0.15 | −$0.08 | +46.7% |
| Nov 2025 | −$0.26 | −$0.16 | +38.5% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Jul 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$0.13 | — | — | $23.6M | — | — |
| Aug 5, 2026 | −$0.18 | −$0.08 | +56.4% | $21.7M | $23.4M | +7.7% |
| May 6, 2026 | −$0.19 | −$0.16 | +15.8% | $18.5M | $19.7M | +6.7% |
| Mar 4, 2026 | −$0.15 | −$0.08 | +46.7% | $20.3M | $20.4M | +0.2% |
| Nov 6, 2025 | −$0.26 | −$0.16 | +38.5% | $20.4M | $19.9M | −2.2% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 8, 2025 | ||||||
| Mar 5, 2025 | ||||||
| Nov 7, 2024 | ||||||
| Aug 1, 2024 | ||||||
| May 2, 2024 | ||||||
| Mar 7, 2024 | ||||||
| Nov 7, 2023 | ||||||
| Aug 3, 2023 | ||||||
| May 4, 2023 | ||||||
| Mar 13, 2023 | ||||||
| Nov 10, 2022 | ||||||
| Aug 11, 2022 | ||||||
| May 10, 2022 | ||||||
| Mar 24, 2022 | ||||||
| Nov 10, 2021 | ||||||
| Aug 12, 2021 | ||||||
| Jul 15, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Sep 30, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||